The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers

Journal of Pathology

Volumn 229, Issue 4, 2013, Pages 630-639

  Cohen Eliav, Michal ^a   Golan Gerstl, Regina ^a   Siegfried, Zahava ^a   Andersen, Claus L ^b   Thorsen, Kasper ^b   Ørntoft, Torben F ^b   Mu, David ^c   Karni, Rotem ^a  

^a HEBREW UNIVERSITY   (Israel)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

amplification; cancer; colon; lung; oncoprotein; splicing; SRSF6

Indexed keywords

MYC PROTEIN; ONCOPROTEIN; ONCOPROTEIN SRSF6; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CELL TRANSFORMATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE AMPLIFICATION; GENE DOSAGE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UPREGULATION;

ADENOCARCINOMA; ALTERNATIVE SPLICING; ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PHOSPHOPROTEINS; PROTEIN ISOFORMS; RNA SPLICING; RNA-BINDING PROTEINS; UP-REGULATION;

EID: 84874087676     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4129     Document Type: Article

References (53)

1. Karni R, de Stanchina E, Lowe SW, et al,. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 2007; 14 (3): 185-193.
2. Golan-Gerstl R, Cohen M, Shilo A, et al,. Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. Cancer Res 2011; 71 (13): 4464-4472.
3. Lefave CV, Squatrito M, Vorlova S, et al,. Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. EMBO J 2011; 30 (19): 4084-4097.
4. Papaemmanuil E, Cazzola M, Boultwood J, et al,. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011; 365 (15): 1384-1395.
5. Graubert TA, Shen D, Ding L, et al,. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 2012; 44 (1): 53-57.
6. Quesada V, Conde L, Villamor N, et al,. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012; 44 (1): 47-52.
7. Huang Y, Steitz JA,. SRprises along a messenger's journey. Mol Cell 2005; 17 (5): 613-615.
8. Long JC, Caceres JF,. The SR protein family of splicing factors: master regulators of gene expression. Biochem J 2009; 417 (1): 15-27.
9. Shepard PJ, Hertel KJ,. The SR protein family. Genome Biol 2009; 10 (10): 242.
10. Zhong XY, Wang P, Han J, et al,. SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 2009; 35 (1): 1-10.
11. Watermann DO, Tang Y, Zur Hausen A, et al,. Splicing factor Tra2-β1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res 2006; 66 (9): 4774-4780.
12. Karni R, Hippo Y, Lowe SW, et al,. The splicing-factor oncoprotein SF2/ASF activates mTORC1. Proc Natl Acad Sci USA 2008; 105 (40): 15323-15327.
13. Anczukow O, Rosenberg AZ, Akerman M, et al,. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol 2012; 19 (2): 220-228.
14. Screaton GR, Caceres JF, Mayeda A, et al,. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 1995; 14 (17): 4336-4349.
15. Nagel RJ, Lancaster AM, Zahler AM,. Specific binding of an exonic splicing enhancer by the pre-mRNA splicing factor SRp55. RNA 1998; 4 (1): 11-23.
16. Caceres JF, Screaton GR, Krainer AR,. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev 1998; 12 (1): 55-66.
17. Tran Q, Roesser JR,. SRp55 is a regulator of calcitonin/CGRP alternative RNA splicing. Biochemistry 2003; 42 (4): 951-957.
18. Fic W, Juge F, Soret J, et al,. Eye development under the control of SRp55/B52-mediated alternative splicing of eyeless. PLoS One 2007; 2 (2): e253.
19. Juge F, Fernando C, Fic W, et al,. The SR protein B52/SRp55 is required for DNA topoisomerase I recruitment to chromatin, mRNA release and transcription shutdown. PLoS Genet 2010; 6: e1001124.
20. Ring HZ, Lis JT,. The SR protein B52/SRp55 is essential for Drosophila development. Mol Cell Biol 1994; 14 (11): 7499-7506.
21. Gabut M, Dejardin J, Tazi J, et al,. The SR family proteins B52 and dASF/SF2 modulate development of the Drosophila visual system by regulating specific RNA targets. Mol Cell Biol 2007; 27 (8): 3087-3097.
22. Rasheva VI, Knight D, Bozko P, et al,. Specific role of the SR protein splicing factor B52 in cell cycle control in Drosophila. Mol Cell Biol 2006; 26 (9): 3468-3477.
23. Aguilera A, Garcia-Muse T,. R loops: from transcription byproducts to threats to genome stability. Mol Cell 2012; 46 (2): 115-124.
24. Jiang CC, Lai F, Tay KH, et al,. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. Cell Death Dis 2010; 1: e69.
25. Filippov V, Schmidt EL, Filippova M, et al,. Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes. Gene 2008; 420 (1): 34-41.
26. Nowak DG, Woolard J, Amin EM, et al,. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci 2008; 121 (20): 3487-3495.
27. Carter JG, Cherry J, Williams K, et al,. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease. Curr Eye Res 2011; 36 (4): 328-335.
28. Golan-Gerstl R, Wallach-Dayan SB, Zisman P, et al,. c-FLIP deviates myofibroblast Fas-induced apoptosis towards proliferation during lung fibrosis. Am J Respir Cell Mol Biol 2012; 47: 271-9.
29. Wallach-Dayan SB, Golan-Gerstl R, Breuer R,. Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis. Proc Natl Acad Sci USA 2007; 104 (51): 20460-20465.
30. McCurrach ME, Lowe SW,. Methods for studying pro- and antiapoptotic genes in nonimmortal cells. Methods Cell Biol 2001; 66: 197-227.
31. Bengtsson H, Wirapati P, Speed TP,. A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 and 6. Bioinformatics 2009; 25 (17): 2149-2156.
32. Lamy P, Wiuf C, Orntoft TF, et al,. Rseg-an R package to optimize segmentation of SNP array data. Bioinformatics 2011; 27 (3): 419-420.
33. Sen S, Talukdar I, Liu Y, et al,. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer. J Biol Chem 2010; 285 (33): 25426-25437.
34. Talukdar I, Sen S, Urbano R, et al,. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene. PLoS One 2011; 6 (11): e27869.
35. Belfiore A, Frasca F, Pandini G, et al,. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 2009; 30 (6): 586-623.
36. Giudice J, Leskow FC, Arndt-Jovin DJ, et al,. Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B. J Cell Sci 2011; 124 (5): 801-811.
37. Vella V, Pandini G, Sciacca L, et al,. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 2002; 87 (1): 245-254.
38. Scheper GC, Morrice NA, Kleijn M, et al,. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells. Mol Cell Biol 2001; 21 (3): 743-754.
39. Scheper GC, Parra JL, Wilson M, et al,. The N- and C-termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization. Mol Cell Biol 2003; 23 (16): 5692-5705.
40. Fuja TJ, Lin F, Osann KE, et al,. Somatic mutations and altered expression of the candidate tumor suppressors CSNK1Ïμ, DLG1, and EDD/hHYD in mammary ductal carcinoma. Cancer Res 2004; 64 (3): 942-951.
41. Gardiol D, Zacchi A, Petrera F, et al,. Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression. Int J Cancer 2006; 119 (6): 1285-1290.
42. Yamanaka T, Ohno S,. Role of Lgl/Dlg/Scribble in the regulation of epithelial junction, polarity and growth. Front Biosci 2008; 13: 6693-6707.
43. Zammarchi F, de Stanchina E, Bournazou E, et al,. Antitumorigenic potential of STAT3 alternative splicing modulation. Proc Natl Acad Sci USA 2011; 108 (43): 17779-17784.
44. Venables JP,. Aberrant and alternative splicing in cancer. Cancer Res 2004; 64 (21): 7647-7654.
45. Venables JP, Klinck R, Koh C, et al,. Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 2009; 16 (6): 670-676.
46. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144 (5): 646-674.
47. Shiu KK, Natrajan R, Geyer FC, et al,. DNA amplifications in breast cancer: genotypic-phenotypic correlations. Future Oncol 2010; 6 (6): 967-984.
48. Hoffman B, Liebermann DA,. Apoptotic signaling by c-MYC. Oncogene 2008; 27 (50): 6462-6472.
49. Larsson LG, Henriksson MA,. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res 2010; 316 (8): 1429-1437.
50. Chang L, Chiang SH, Saltiel AR,. Insulin signaling and the regulation of glucose transport. Mol Med 2004; 10 (7-12): 65-71.
51. Leto D, Saltiel AR,. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 2012; 13 (6): 383-396.
52. Ghigna C, Giordano S, Shen H, et al,. Cell motility is controlled by SF2/ASF through alternative splicing of the Ron proto-oncogene. Mol Cell 2005; 20 (6): 881-890.
53. Han J, Ding JH, Byeon CW, et al,. SR proteins induce alternative exon skipping through their activities on the flanking constitutive exons. Mol Cell Biol 2011; 31 (4): 793-802.